LYMPHOMA NON-HODGKIN
Clinical trials for LYMPHOMA NON-HODGKIN explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA NON-HODGKIN trials appear
Sign up with your email to follow new studies for LYMPHOMA NON-HODGKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat blood cancers in early trial
Disease control Not yet recruitingThis early-stage study tests a new drug called LY4152199 in about 215 adults with B-cell cancers like lymphoma that have come back or not responded to prior treatment. The drug is designed to help the body's immune cells attack cancer cells. The main goals are to find the safest …
Matched conditions: LYMPHOMA NON-HODGKIN
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 02:16 UTC
-
New drug combo aims to boost lymphoma treatment
Disease control Not yet recruitingThis study tests a new drug, epcoritamab, added to standard chemotherapy (R-CHOP) for people newly diagnosed with an aggressive form of B-cell lymphoma. The main goal is to check for a specific side effect called cytokine release syndrome. About 20 adults will take part in this e…
Matched conditions: LYMPHOMA NON-HODGKIN
Phase: PHASE2 • Sponsor: Mwanasha Merrill, MD • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New immunotherapy MK-1045 takes on tough lymphomas
Disease control Not yet recruitingThis early-stage study tests MK-1045, an immunotherapy that helps the immune system fight cancer, in people with two types of non-Hodgkin lymphoma (follicular and diffuse large B-cell). About 200 participants whose cancer has returned or not responded to at least two prior treatm…
Matched conditions: LYMPHOMA NON-HODGKIN
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Can a big vitamin d boost help lymphoma patients? new trial aims to find out
Disease control Not yet recruitingThis study tests whether a high-dose vitamin D2 regimen can raise blood vitamin D levels faster than the standard weekly dose in people newly diagnosed with an aggressive type of non-Hodgkin lymphoma. About 52 participants will be randomly assigned to one of the two dosing plans …
Matched conditions: LYMPHOMA NON-HODGKIN
Phase: NA • Sponsor: Phramongkutklao College of Medicine and Hospital • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Can music and mindfulness ease the toll of stem cell transplants?
Symptom relief Not yet recruitingThis study tests an online program that combines mindfulness and music therapy to help people undergoing stem cell transplants feel better and have fewer symptoms. About 165 adults with blood cancers like leukemia or lymphoma will take part. The goal is to see if this approach im…
Matched conditions: LYMPHOMA NON-HODGKIN
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated May 17, 2026 02:08 UTC
-
Healthy volunteers help track new lymphoma Drug's path through the body
Knowledge-focused Not yet recruitingThis early-stage study gives a single dose of a radioactive-labeled drug, DZD8586, to 6 healthy men aged 18-45. The goal is to see how the body absorbs, breaks down, and gets rid of the drug. Results will help design future studies for people with non-Hodgkin lymphoma.
Matched conditions: LYMPHOMA NON-HODGKIN
Phase: PHASE1 • Sponsor: Dizal Pharmaceuticals • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC